Leaders leverage vast expertise to grow customer base, innovate new solutions and support clinicians
boston, January 12, 2023 /PRNewswire/ — Neurology, a provider of evidence-based, personalized, digital therapeutic and virtual care solutions for treating and managing patients with neurological conditions, today announced the depth and reality of its leadership team. announced that it has expanded its experience in the world. Three leaders who are active in their respective fields. Neuroglee’s new Chief Medical Officer (CMO), Chief Technology Officer (CTO), and Senior Vice President of Clinical Strategy and Operations will provide expertise in neurocognitive patient care and research, and focus on digital health and data throughout his career. It’s been a science-driven success.
Sheila MyersMD, MS, CPE, New CMO of Neurology. As an experienced neurologist and physician executive, Dr. Myers believes that physicians managing patients with neurological disorders can benefit from both digital health and remote virtual clinic support from Neurology’s unique multidisciplinary neurocognitive care team. Allowing you to maximize the value of Neurology’s offerings, including: Dr. Myers will primarily mentor, educate and support external physicians and other clinicians who have prescribed her Neuroglee Connect platform to patients, as well as consult internal clinicians on improving patient care and quality. .
The opportunity to lead the industry in new care delivery models that combine advanced data science, remote patient monitoring and virtual care to slow the progression of highly complex conditions motivated Dr. Myers to join Neurology’s leadership team.
“Neuroglee is the first to observe a clear link between non-pharmacological interventions for patients with neurocognitive impairment and adaptive models of care that can slow disease decline and give patients hope for improvement. I did it,” said Dr. Myers. “This is unique in an environment where for more than 20 years there has been inadequate access to neurologists and a clear lack of effective treatments. It’s exciting to see interventions that are both stabilizing and preventive – understanding their disease and working together to prevent it.”
Prior to joining Neuroglee, Dr. Myers was Vice President and CMO of Atrium Health Pineville. Charlotte, North Carolina, was Regional Medical Director of the Atrium Neuroscience Institute – Neurology. Prior to Atrium, Dr. Myers was a neurologist at Inova Health System. She graduated from university with a Bachelor’s degree in Biology and Bioethics. University of Virginia MSc in Physiology and Biophysics from Georgetown UniversityAfter earning her medical degree GeorgetownDr. Myers Completed a Neurology Residency Emory University When Georgetownand a fellowship in clinical neurophysiology.
Ramesh Natarajan CTO of Neurology. With over 20 years of his IT product development and cybersecurity experience, Natarajan is responsible for ensuring front-end and back-end performance, reliability, usability, security, and data privacy of the NeuroGreeConnect digital health platform. bear the On the front end, Natarajan ensures the user interface is intuitive and engaging, providing a seamless experience for patients and caregivers across multiple therapeutic, diagnostic, and educational components of the solution. Natarajan will also continue to work on the backend components of Neuroglee Connect, including the collection of streaming data from patient digital therapies, wearables, assessments, and other inputs that feed into automatic adaptive learning powered by machine learning (ML). improvement. A process that supports clinicians in creating the most effective and personalized care plans that identify opportunities for intervention.
Natarajan’s background in development and leadership is well suited to guide the continuous improvement of Neuroglee Connect’s artificial intelligence (AI) and ML capabilities. Most recently, as vice president of engineering at cybersecurity company CyGlass, Natarajan uses his AI and ML engines in the cloud to identify, detect, and identify threats on networks without the need for clients to update software or hardware. I created a corresponding solution.
“I was drawn to neurology because of how big a solution could be for a large, complex health problem that continues to grow when the last generation of baby boomers turns 65 in 2030. It was about being able to make an impact,” said Natarajan. “With no established standard of care, it is up to companies like Neurology to deliver digital therapies that can help slow the progression of neurodegenerative diseases, directed and monitored by clinicians. Building a digital health platform with management and user-designed elements to help us fulfill our mission is a very rewarding responsibility.”
Natarajan completed an undergraduate degree in Computer Science and Engineering. national college of technology At Trichy, IndiaAfter that, I completed my Master of Business Administration. University of Massachusetts Amherst.
Pia Banerjeedoctorate, Senior Vice President of Clinical Strategy and Operations for Neurology. As an executive clinician, she designs and oversees neurology’s clinical care pathway. This includes creating patient journeys to achieve clinical outcomes and optimizing patient and care her partner experiences across digital treatments and virtual clinics her solutions. Dr. Banerjee will also lead reimbursement scaling strategies and scientific approaches to ensure Neurology delivers maximum value to healthcare systems, patients and payers.
Prior to Neurology, Dr. Banerjee was Head of Neuropsychological Research Operations at St. Jude Children’s Research Hospital. memphisThere, she led a cross-departmental team spanning program development, operations, and patient care for a national longitudinal cognitive health study of cancer survivors of all ages, including older adults. Dr. Banerjee also launched and scaled telemedicine and digital health initiatives across the hospital.
“In studying the mechanisms and trajectories of neurological conditions, we have seen first-hand how treatment options are often limited for patients when cognitive impairment is first detected,” Banerjee said. said Dr. “Neuroglee offers patients experiencing early-stage cognitive impairment an option to improve their cognitive trajectory, promote emotional and physical health, and improve their quality of life. It is effective for patients and provides the greatest benefit to patients and care partners.”
Dr. Banerjee received a Bachelor’s degree in Biology from college. Massachusetts Institute of Technologyholds a Master’s and Ph.D. in Psychology University of Washington of St. LouisShe completed an internship and fellowship in clinical neuropsychology. UCLAspecializing in neurological disorders.
“Being able to attract experienced leaders like Sheila, Ramesh and Pia is a tremendous advantage for Neurology, serving a market with significant care gaps for patients with neurodegenerative and other neurological disorders. We are entering our next phase of growth,” said CEO Aniket Singh Rajput. “Their decades of knowledge and expertise are combined with a passionate commitment to improving neurological care, expanding and expanding the life-changing services and experiences they provide to patients and their families. While optimizing, we enable providers to deliver optimal results more efficiently by reducing demand on their time and resources.”
Learn more about the entire Neuroglee leadership team here.
Neuroglee discovers, develops and commercializes personalized evidence-based digital therapeutics (DTx) and virtual care solutions to treat and manage patients with neurodegenerative diseases. The company is also breaking new ground by offering a first-of-its-kind virtual specialist treatment clinic for patients diagnosed with mild cognitive impairment associated with difficult-to-treat conditions such as Alzheimer’s disease. I’m here. Neurology’s adaptive learning platform uses several new digital biomarkers to leverage machine learning to dynamically and continuously personalize and optimize treatment based on patients’ unique cognitive and physical needs. become By combining best-in-class cognitive rehabilitation strategies with telecare management, Neurology can be used alone or in combination with pharmacotherapy to treat patients with mild cognitive impairment due to Alzheimer’s disease or other neurodegenerative conditions. Helps slow or delay the worsening of symptoms in. For more information, visit neuroglee.com.
Amendra Communications for Neurology
View original content and download multimedia: https://www.prnewswire.com/news-releases/neuroglee-expands-executive-team-with-experts-in-real-world-neurocognitive-patient-care- leadership-research-and-data-science-301720420.html
Source Neurology Therapeutics